High-tech Rehabilitation Impact on Muscle MRI
Launched by IRCCS EUGENIO MEDEA · Mar 13, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The use of high-tech techniques is becoming increasingly popular in the rehabilitation field, where the use of exoskeletons, robots, virtual reality, etc. allow for very refined control of the rehabilitation process, making it more repeatable and, at the same time, more customization on the needs of the individual patient. Furthermore, the use of virtual reality and applications with video game-style scenarios increase the patient's involvement and active participation, one of the crucial factors for maximizing the effectiveness of rehabilitation treatment, especially in the pediatric field...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients undergoing high-tech rehabilitation treatment of the lower limb
- • able to remain in a supine position for 30 minutes without moving
- • able to follow instructions and communicate effectively with operators (e.g communicating fear and/or pain)
- Exclusion Criteria:
- • any contraindication to MRI examination
- • presence of metal nails/protheses or objects near the thighs which will disrupt and/or induce distortion on the MR images
About Irccs Eugenio Medea
IRCCS Eugenio Medea is a leading clinical research institute based in Italy, dedicated to advancing pediatric healthcare through innovative research and evidence-based practices. As a recognized center of excellence, it focuses on multidisciplinary approaches to address complex health challenges in children and adolescents, particularly in the fields of neurodevelopmental disorders, mental health, and rehabilitation. The institute collaborates with national and international partners to conduct rigorous clinical trials, aiming to translate scientific discoveries into effective therapeutic interventions. Committed to enhancing patient outcomes, IRCCS Eugenio Medea prioritizes ethical standards and patient safety in all its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bosisio Parini, Lc, Italy
Patients applied
Trial Officials
Denis Peruzzo, PhD
Principal Investigator
Scientific Institute IRCCS Eugenio Medea
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported